|
⚲
|
| Tioga Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001331886 |
| Sale | 2010-02-10 ($18.3 M Offered, $9.3 M Sold) |
| Fund | |
| Phone | 8586776077 |
| Address | 9393 Towne Centre Dr San Diego, 92121 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Martin Meunchbach | |
| James Niedel | |
| Martin Muenchbach | |
| Arno Hartmann | |
| Allen Mangel | |
| David Urso | |
| Stuart Collinson |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
GAM Global Rates Series, a Series of LHP Atlas Fund, LLC
✚
|
0.0 | |
|
Gander Multi-Strategy Fund, LP
✚
|
0.0 | |
|
Gandy John Wilson
✚
|
0.0 | |
|
Greystar Logistics Coinvestment Partners I, LP
✚
|
0.0 | |
|
Greystone Monticello Funding SH-63 LLC
✚
|
0.0 | |
|
Grey Street Ventures III LLC
✚
|
0.0 | |
|
Greywolf Opportunities Offshore Fund II LP
✚
|
0.0 | |
|
Greywolf Opportunities Onshore Fund II LP
✚
|
0.0 | |
|
Griffin Clifford R.
✚
|
0.0 | |
|
GAM Global Rates Segregated Portfolio, a Segregated Portfoli
✚
|
0.0 |